Star Combo Pharma Limited / Fundamentals
Income statement
- Net revenue
€20.39M - Cost of goods sold
€16.07M - Gross profit
€4.31M - SG&A expenses
€3.68M - R&D expenses
€0.00 - EBITDA
€1.24M - D&A
€417.30K - EBIT
€636.19K - Interest expenses
€97.86K - EBT
€805.67K - Tax expenses
€131.35K - Net income
€674.32K
Cash flow statement
- Net deferred tax
€13.93K - Non-cash items
€2.09M - Changes in working capital
-€634.31K - Operating cash flow
€2.64M - Capex
€827.09K - Other investing cash flow
-€2.00M - Net investing cash flow
-€2.32M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
-€265.06K - Net financing cash flow
-€265.06K - Foreign exchange effects
€0.00 - Net change in cash
-€2.33M - Cash at end of period
€0.00 - Free cash flow
€3.46M
Balance sheet
- Cash and cash equivalents
€2.10M - Cash and short-term investments
€7.23M - Total receivables
€1.16M - Inventory
€2.44M - Other current assets
€120.49K - Total current assets
€10.95M - Property, plant & equipment
€12.63M - Goodwill
€0.00 - Intangible assets
€374.20K - Long-term investments
€0.00 - Other non-current assets
€204.10K - Total non-current assets
€13.21M - Total assets
€24.17M - Accounts payable
€2.53M - Short-term debt
€83.33K - Other current liabilities
€270.82K - Total current liabilities
€2.89M - Long-term debt
€2.11M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€316.11K - Total non-current liabilities
€2.43M - Total liabilities
€5.31M - Common stock
€37.54M - Retained earnings
-€5.47M - Other equity
-€13.33M - Total equity
€18.85M - Total liabilities and shareholders' equity
€24.17M
Company information
- Market capitalization
€10.21M - Employees
0 - Enterprise Value
€18.40M
Company ratios
- Gross margin
-
21.1% Worse than peer group: 36.5% - EBITDA margin
-
6.1% Much better than peer group: -120.6% - EBIT margin
-
3.1% Much better than peer group: -125.5% - EBT margin
-
4.0% Much better than peer group: -191.2% - Net margin
-
3.3% Much better than peer group: -186.9% - ROE
-
3.6% Much better than peer group: -603.0% - ROA
-
2.8% Much better than peer group: -55.9% - Asset turnover
-
84.4% Much worse than peer group: 179.5% - FCF margin
-
8.9% Much better than peer group: -84.5% - FCF yield
17.7% - Efficiency ratio
93.9% - Net sales per employee
-
€0.00 - Net income per employee
-
€0.00